Dermapharm Holding SE buy PapaSmurf
Summary
This prediction ended on 08.03.24 with a price of €37.54. With a performance of -4.14%, the BUY prediction by PapaSmurf finished with a loss. PapaSmurf has a follow-up prediction for Dermapharm Holding SE where he still thinks Dermapharm Holding SE is a Buy. PapaSmurf has 50% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Dermapharm Holding SE | -1.418% | -1.418% | -27.301% |
iShares Core DAX® | 1.056% | 1.056% | 18.108% |
iShares Nasdaq 100 | -1.886% | -0.160% | 26.970% |
iShares Nikkei 225® | 2.553% | 4.359% | 17.676% |
iShares S&P 500 | -0.434% | 0.224% | 24.986% |
Comments by PapaSmurf for this prediction
In the thread Trading Dermapharm Holding SE